CAIX / CA9蛋白產(chǎn)品信息

別名: CA9
表達(dá)方式: 
A DNA sequence encoding the canine CA9 (Met1-Leu410) was expressed with a C-terminal polyhistidine tag.
種屬: Canine
表達(dá)宿主: Human Cells

CAIX / CA9 Protein QC Testing

純度: >85% as determined by SDS-PAGE SDS-PAGE
內(nèi)**: < 1.0 EU per μg of the protein as determined by the LAL method
穩(wěn)定性: Samples are stable for up to twelve months from date of receipt at -70℃
預(yù)測(cè)N端: Gln 38
分子量: 
The recombinant canine CA9 comprises 384 amino acids and has a predicted molecular mass of 42.1 kDa. The apparent molecular mass of the protein is approximately 50 kDa in SDS-PAGE under reducing conditions due to glycosylation.
緩沖液: Lyophilized from sterile PBS, pH7.4
Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
Please contact us for any concerns or special requirements.

CAIX / CA9 Protein Usage Guide

儲(chǔ)存方法: Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution: A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

CAIX / CA9蛋白背景綜述

Carbonic anhydrases IX (CAIX), also known as membrane antigen MN or CA9, is a member of the carbonic anhydrase (CA) family and may be involved in cell proliferation and cellular transformation. CAs are zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide ( H2O + CO2 = H+ + HCO3- ) and thus participate in a variety of biological and physical processes. CAIX is a transmembrane protein structurally consisting of a signal peptide, a proteoglycan-related region, a CA domain with a highly conserved active site, a transmembrane anchor and an intracytoplasmic tail, and is the only tumor-associated CA isoenzyme known so far. Compared with normal tissues, CAIX is overexpressed in a wide spectrum of tumor types and associated with increased metastasis and poor prognosis in aggressive carcinomas. CAIX expression is cell density dependent and has been shown to be strongly induced by hypoxia, accordingly facilitates adaptation of tumor cells to hypoxic conditions. CA9 is regarded as a new therapeutic target for CA9-derived carcinomas.

參考文獻(xiàn)

Pastorek J. et al., 1994, Oncogene. 9: 2877-88.
Opavsky R. et al., 1996, Genomics. 33: 480-7.
Swietach P. et al., 2008, J Biol Chem. 283: 20473-83.
Robertson N. et al., 2004, Cancer Res. 64: 6160-5.
Bui MH. et al., 2003, Clin Cancer Res. 9: 802-11.
Choi SW. et al., 2008, Hum Pathol. 39: 1317-22.

規(guī)格：10ug

關(guān) 鍵 詞：Canine CAIX / CA9 Protein,實(shí)驗(yàn)說(shuō)明,廠家價(jià)格，實(shí)驗(yàn)室耗材，生化試劑，上海創(chuàng)賽，博飛美科，實(shí)驗(yàn)儀器，廠家

CANSPEC品質(zhì)提供的Canine CAIX / CA9 Protein|實(shí)驗(yàn)說(shuō)明|廠家價(jià)格性能**，其優(yōu)良的品質(zhì)滿(mǎn)足您不同實(shí)驗(yàn)的多種需求。

本產(chǎn)品由上海創(chuàng)賽品質(zhì)提供，歡迎咨詢(xún)國(guó)內(nèi)免費(fèi)服務(wù)專(zhuān)線(xiàn)：400-608-7598，更多產(chǎn)品信息請(qǐng)登錄www.ahbcpqn.cn 或 www.4006087598.com